‘AI lowers the capital needed’: India’s drug discovery push faces test of human trials
Indian scientists and biopharmaceutical firms are using artificial intelligence to identify promising drug candidates faster and at lower cost. But industry experts tell CNA the technology can address only part of a lengthy and risky development process.